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Available online 14 September 2011AbstractBackground: Somatostatin (SST) has been proven to have cardioprotective effects, but its effects on endothelial cells has not yet well studied.
Aim: To confirm the phenomenon of SST-induced preconditioning (PC) and the cellular mechanisms involved, we designed an in vitro study to
investigate the effects of SST analogs on tumor necrosis factor (TNF)-a-induced endothelial nuclear factor (NF)-kB activation with subsequent
interleukin (IL)-6 and IL-8 release.
Methods: Experiments were performed on primary human umbilical-vein endothelial cells (HUVECs). IL-6 and IL-8 were measured using
commercial enzyme-linked immunosorbent assay kits. An electrophoretic mobility shift assay (EMSA) was used to demonstrate NF-kB acti-
vation. The effects of pretreatment with octreotide, an SST analog, and/or N-acetyl-cysteine (NAC) were tested.
Results: TNF-a stimulated IL-6 and IL-8 production from HUVECs. SST PC using octreotide at concentrations >108 M attenuated TNF-a-
induced IL-6 and IL-8 release, but NAC did not inhibit SST-treated endothelial cells stimulated by TNF-a. EMSA revealed that TNF-a treatment
was associated with activation of NF-kB, which could be inhibited by SST PC. By contrast, wortmannin and AG-490 reversed the inhibitory
effects of octreotide on TNF-a-induced NF-kB activation, but neither had any definite effects on TNF-a-induced NF-kB activation in the
absence of octreotide. Western blots confirmed that octreotide modulated Ikk at 108 M.
Conclusion: SST PC modulates Ikk in a PI3K- and JAK-2-dependent pathway, which in turn attenuates activation of NF-kB induced by TNF-a
in HUVECs.
Copyright  2011, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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We previously demonstrated manymodes of preconditioning
(PC) in experiments to show cardioprotective effects.1e3 PC
represents a powerful intervention that reduces infarct size after
ischemiaereperfusion or other pretreatments such as stimula-
tion or induction of the adrenergic system,4 adenosine recep-
tors,5 ATP-sensitive potassium channels,6 heat shock proteins,7
and oxidative stress.8 Some investigators further studied the* Corresponding author. Department of Emergency Medicine, Shin-Kong
Wu Ho-Su Memorial Hospital, 95 Wen Chang Road, Taipei, Taiwan.
E-mail address: m002183@ms.skh.org.tw (T.-L. Wang).
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doi:10.1016/j.jacme.2011.07.005possible effector cells of such PC. Although we proposed that
neutrophils are target cells for PC,1 endothelial cells are still the
main effectors cells used in most research.2,9e11
Endothelial cells are associated with many pathophysiolog-
ical changes that may be related to PC. Theoretically, endo-
thelial PC should be closely related to the mechanisms of PC
mentioned above.6 However, the real link between endothelial
PC and myocardial PC deserves further investigation. One of
the mechanisms involved in endothelial PC is oxidative stress. It
has been suggested that oxidative stress and cellular redox
status are significant modulators of intracellular signaling.12
Zahler et al9 demonstrated that endothelial cells can be pre-
conditioned by transient intracellular redox stress to reduceMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
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the transcription factor nuclear factor (NF)-kB may facilitate
novel approaches directed at alleviating reperfusion damage.
Because it has been demonstrated that mechanical stretch can
activate matrix metalloprotease expression via tumor necrosis
factor (TNF)-a and the NF-kB pathway,13 NF-kB may be the
central mediator of endothelial PC, whereas mitochondrial
ATP-sensitive potassium (mitoKATP) channels are believed to
be the core mediators of myocardial PC. We previously
demonstrated a reduction in infarct size due to SST PC,3 so it
seemed reasonable to investigate if SST PC could also decrease
damage due to TNF-a as an additional protective mechanism.
We thus designed an in vitro study to investigate the
phenomenon of SST-induced PC and the signaling mecha-
nisms involved in human endothelial cells.2. Methods2.1. Primary culture of human umbilical-vein
endothelial cellsEndothelial cells were cultured from human umbilical veins
(<24 hours post partum) using a modification of the method
described by Jaffe et al.14 After cannulation at both ends, cords
were flushed with 120 mLof HEPES-buffered saline (10 mM)
and incubated with 0.2% collagenase (Sigma, St. Louis, MO,
USA) at 37C for 15 minutes. HUVECs were grown to 100%
confluence on gelatin-coated T25 flasks (Becton Dickinson,
Franklin Lakes, NJ, USA) in medium 199 supplemented with
20% fetal calf serum, 100 IU/mL penicillin, 100 mg/mL strep-
tomycin, 10 mM HEPES, and 0.2 M L-glutamine (Sigma) at pH
7.4 and 37C. Purification was determined by flow cytometry
(FACS, Becton Dickinson) with a factor VIII-related antigen
antibody. Endothelial cells in the first passage were used for
experiments.2.2. STT PC experimental protocolIn PC experiments, medium was removed from confluent
HUVECs and replaced with PBS containing octreotide (an SST
analog at 1010 M, 108 M, or 106 M) for 5 minutes at 37C.
The supernatant was then removed and cells were covered with
standard medium again and incubated with TNF-a (2.5 ng/mL)
for 4 hours. The supernatant was then sampled for measurement
of IL-6 and IL-8. Cells were detached. Time-matched controls
were treated with neither octreotide nor TNF-a. Further exper-
imental groups consisted of cells treated with octreotide (5
minutes) or TNF-a (4 hours) alone. For comparison, experi-
ments were repeated in cells pretreated with the intracellular
radical scavenger N-acetyl-cysteine (NAC, 1 mM) for 30
minutes in comparative groups. After incubation, the cells were
washed to remove all extracellular NAC and then subjected
to the aforementioned procedures. Some experiments were
terminated at 5 minutes or 30 minutes after SST treatment for
analysis of subcellular NF-kB localization.2.3. Interleukin ELISALevels of the cytokines IL-6 and IL-8 were determined in
cell culture supernatants using commercial enzyme-linked
immunosorbent assay (ELISA) kits (Endogen, Woburn, MA,
USA). To determine IL-8, samples were diluted 1:100. Sample
aliquots of 50 mL per well were used in all cases and
measurements were performed according to the manufacturer’s
instructions. In brief, ELISA plates were incubated with stan-
dards or samples for 60 minutes. Unbound cytokine was
removed by washing three times, and a second antibody
(labeled enzymatically for photometric detection) was added.
After further incubation and removal of unbound antibody by
washing, the plates were analyzed photometrically using
a microplate reader (Dynatech, Guernsey, UK) at 450 nm. As an
indicator of cell death, release of lactate dehydrogenase into the
supernatant was also measured photometrically at 490 nm.2.4. NF-kB electrophoretic mobility shift assayThe protein content of nuclear extracts was determined
using a BioRad (Hercules, CA, USA) protein assay. Oligo-
nucleotide sequences were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). A double-strand NF-
kB consensus oligonucleotide probe (50-AGT TGA GGG GAC
TTT CCC AGG-30) was labeled with 32P and 4 mg of nuclear
protein in 2 mL of nuclear extract was mixed with 20 pmol of
[g-32P] dATP-labeled consensus or mutant oligonucleotide in
a total volume of 20 mL at room temperature for 30 minutes.
The samples were then resolved on a 4% polyacrylamide gel.
Gels were dried and imaged by autoradiography at 70C.2.5. Signaling pathways for TNF-a and STT PCTo elucidate the underlying signaling mechanisms,
HUVECs were subjected to different pretreatment protocols,
including AG-490 [100 mM; a Janus-associated kinase (JAK)-
2 antagonist], PD98059 [50 mM; a p42/p44 mitogen-activated
protein kinase (MAPK) inhibitor], genistein (40 mM; a tyro-
sine kinase inhibitor) and wortmannin (50 nM; a phosphoino-
sitide-3-kinase (PI3K) inhibitor).2.6. Ikk protein expressionHUVECs were lysed in a reducing Triton lysis buffer (Tris
1 mM, NaCl 50 mM, Triton X, sodium vanadate 5 mM, NaF
50 mM, Na pyrophosphate 30 mM, DTT 1 mM, PMSF 1 mM,
leupeptin 10 mM, pepstatin 10 mM). Nuclear and cytosolic
fractions were separated by centrifugation (10,000 g for 5
seconds) and the membrane fraction was removed by centri-
fugation at 10,000 g (4C) for 15 minutes. The protein
concentration in nuclear and cytosolic lysates was determined
using a detergent-compatible assay (BCA, Pierce, Rockford,
IL, USA). Aliquots (40 mg) of protein were separated on
a 12% polyacrylamide gel, transferred to a nitrocellulose
membrane (Hybond-enhanced chemiluminescence, Amer-
sham, Braunschweig, Germany), blocked with buffer
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primary antibody (anti-IkB; Santa Cruz Biotechnology). After
washing four times with buffer containing 1% nonfat dry milk,
the membranes were exposed to 0.2 mg/mL secondary antibody
labeled with horseradish peroxidase (Santa Cruz Biotech-
nology). The membranes were then incubated with an enhanced
chemiluminescence kit (Pierce) for 1 minute and exposed to X-
ray film. The films were analyzed using a GelDoc 1000 video
system (BioRad) and the optical density of the bands was
calculated using Molecular Analyst software (BioRad). Owing
to considerable interindividual variability, values are expressed
as percentage changes compared to the control (100%). Anal-
ogous experiments were performed on the cytoplasmic fraction
as a control for the purity of the nuclear and cytoplasmic
preparations.2.7. Data analysisAll values are expressed as mean  SEM. Densitometry
data for Western blotting and EMSA were analyzed using
a two-tailed paired t test or two-way analysis of variance
followed by the Bonferroni test when appropriate (SSPS 10.0
for Windows, SPSS, Chicago, IL, USA). A p value <0.05 was
considered to be statistically significant.
3. Results3.1. STT PC effects on TNF-a-induced endothelial IL-6
and IL-8 releaseAs shown in Fig. 1, TNF-a stimulated significant secretion
of IL-6 (8.5  1.9 pg/mL vs. 10.1  0.5 pg/mL, p < 0.05) and
IL-8 (1080  200 pg/mL vs. 1420  50 pg/mL, p < 0.05) by
HUVECs. NAC decreased detectable IL-6 (6.6  0.7 pg/mL
vs. 10.1  0.5 pg/mL, p < 0.01) and IL-8 (1100  200 pg/mLFig. 1. Measurement of IL-6 and IL-8 from human umbilical-vein endothelial
cells. Lane 1: control; lane 2: TNF-a alone; lane 3: TNF-a and pretreatment
with N-acetyl-cysteine (NAC); lane 4: TNF-a, pretreatment with NAC and
octreotide (106 M); lane 5: TNF-a, pretreatment with NAC and octreotide
(108 M); lane 6: TNF-a, pretreatment with NAC and octreotide (1010 M);
lane 7: TNF-a and pretreatment with octreotide (106 M); lane 8: TNF-a and
pretreatment with octreotide (108 M); lane 9: TNF-a and pretreatment with
octreotide (1010 M).vs. 1420  50 pg/mL, p < 0.05). SST PC had significant
inhibitory effects on TNF-a-induced IL-6 and IL-8 secretion at
octreotide concentrations >108 M (IL-6: 6.5  0.6 pg/mL vs.
10.1  0.5 pg/mL, p < 0.01; IL-8: 1120  210 pg/mL vs.
1420  50 pg/mL, p < 0.05). However, NAC had no syner-
gistic effects with SST (e.g., at 108 M octreotide, IL-6:
6.5  0.6 pg/mL without NAC vs. 7.0  0.7 pg/mL with
NAC, p > 0.05; IL-8: 1120  210 pg/mL with NAC vs.
1180  230 pg/mL without NAC, p > 0.05).
In summary, ELISA revealed that TNF-a induced endo-
thelial release of IL-6 and IL-8, which was inhibited by
pretreatment with NAC. SST PC attenuated TNF-a-induced
IL-6 and IL-8 release, but did not inhibit NAC-treated endo-
thelial cells stimulated by TNF-a (Fig. 1).3.2. STT PC inhibits TNF-a-induced NF-kB activation
via a PI3K- and JAK-2-dependent pathwayEMSA revealed that TNF-a induced NF-kB activation
compared to control cells (Lanes 2 and 3, Fig. 2). Neither AG-
490 (a JAK-2 antagonist), PD98059 (a MAPK inhibitor),
genistein (a tyrosine kinase inhibitor) nor wortmannin (a PI3K
inhibitor) had any effects on TNF-a-induced NF-kB activation
(Lanes 10e13, Fig. 2).Fig. 2. Electrophoretic shift mobility assay showing different degrees of NF-
kB activation. Lane 1: control; lane 2: TNF-a alone; lane 3: cold; lane 4:
TNF-a and pretreatment with AG-490 (100 mM); lane 5: TNF-a and
pretreatment with PD98059 (50 mM); lane 6: TNF-a and pretreatment with
wortmannin (50 nM); lane 7 (A þ S): TNF-a, pretreatment with AG-490
(100 mM) and octreotide (108 M); lane 8 (P þ S): TNF-a, pretreatment
with PD98059 (50 mM) and octreotide (108 M); lane 9 (W þ S): TNF-a,
pretreatment with wortmannin (50 nM) and octreotide (108 M); lane 10 (S1):
TNF-a and pretreatment with octreotide (108 M); lane 11 (S2): TNF-a and
pretreatment with octreotide (1010 M).
TNF con cold A P W A+S P+S W+S S1 S2
Fig. 3. Western blots for Ikk levels in HUVECs in the absence or presence of octreotide (108 M), AG-490 (100 mM), and wortmannin (50 nM). Lane 1: TNF-a
alone; lane 2: control; lane 3: cold; lane 4: mutant; lane 5: TNF-a, pretreatment with AG-490 (100 mM) and octreotide (108 M); lane 6: TNF-a, pretreatment with
PD98059 (50 mM) and octreotide (108 M); lane 7: TNF-a, pretreatment with genistein (40 mM) and octreotide (108 M); lane 8: TNF-a, pretreatment with
wortmannin (50 nM) and octreotide (108 M); lane 9: TNF-a, pretreatment with octreotide (108 M); lane 10: TNF-a and pretreatment with AG-490 (100 mM);
lane 11: TNF-a and pretreatment with PD98059 (50 mM); lane 12: TNF-a and pretreatment with genistein (40 mM).
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vation (Lanes 2 and 9, Fig. 3). In addition, wortmannin
markedly reversed the inhibitory effects of SST PC on TNF-a-
induced NF-kB activation (Lanes 8 and 9, Fig. 2). AG-490
also reversed the effects (Lanes 5 and 9, Fig. 2). This
suggests that SST PC inhibits TNF-a-induced NF-kB activa-
tion in a PI3K- and JAK-2-dependent pathway.3.3. STT PC modulates Ikk expression induced by TNF-aWestern blotting revealed that TNF-a induced Ikk expres-
sion by HUVECs (Lanes 1 and 2, Fig. 3). NAC had no effects
on TNF-a-induced Ikk expression (data not shown). However,
SST PC had bimodal effects on TNF-a-induced Ikk expres-
sion. SST PC had significant inhibitory effects on TNF-a-
induced Ikk expression at 108 M (S1, Fig. 3), but the effects
were not significant at 1010 M (S2, Fig. 3). AG-490 (A þ S,
Fig. 3) and wortmannin (W þ S, Fig. 3) reversed the inhibitory
effects of SST PC on TNF-a-induced Ikk expression, whereas
PD98059 had no significant effects (P þ S, Fig. 3).
4. Discussion
This study demonstrated that SST PC can attenuate TNF-a-
induced release of IL-6 and IL-8, which are indicative of
endothelial damage. NF-kB and Ikk signaling are possibly the
pathways responsible. These observations confirm that SST
PC exists in human endothelial cells and may contribute, at
least in part, to in vivo infarct reduction in animal models of
SST PC.3
Activation of G-protein-linked phospholipase C, tyrosine
kinase pathways and protein kinase C and the generation of
oxygen radicals are known to be involved in PC.15 ATP-
sensitive potassium channels are widely considered to be the
most probable triggers and effectors of PC.15 Recent studies
suggest that mitoKATP, in addition to sarcolemmal KATP chan-
nels, might mainly account for the protective mechanism.15e18
It has been proved that mitoKATP channel opening is related to
mitochondrial swelling and optimization of respiration,16
prevention of mitochondrial calcium overload,17 and control
of reactive oxygen radicals,18 all of which are possible links to
cardioprotection during severe myocardial ischemia and
infarction.As mentioned above, the cellular targets of PC seem to be
heterogeneous. Although saline-perfused isolated hearts or
isolated cardiomyocytes can be preconditioned,19,20 a so-called
microvascular component of PC has been proposed.21e23 This
concept involves reduction of post-ischemic inflammation or
the mitigation of leukocyte adhesion in the perfused vascular
bed after PC. Endothelial cells, the interface between paren-
chymal tissue and blood cells, are involved in this significant
pathophysiological process.
We first demonstrated that SST analogs may mimic ischemic
preconditioning in a rat model of myocardial infarction.3
However, it is not known whether this cardioprotective effect
can be attributed to either myocardial PC or endothelial PC.
SST is produced by neuroendocrine, inflammatory, and immune
cells in response to various mediators.24 Its receptors are
a family of seven-transmembrane (TM)-domain G-protein-
coupled receptors that comprise five distinct subtypes termed
SST receptor (SSTR) 1e5 encoded by separate genes on
different chromosomes.24e27 It would be interesting to inves-
tigate if SSTanalogs can exert protective effects in endothelium
via their specific receptors. The data from this study show that
an SST analog can protect HUVECs from TNF-a-induced
damage.
It has been reported that the physiological effects of SSTand
SSTRs depend on insulin-like growth factor-1 (IGF-I) in many
tissues.28,29 It has been reported that IGF-I leads to coronary
arteriolar dilation though activation of potassium channels,30
induction of nitrous oxide,31 and reduction of intracellular
calcium from vascular endothelium.32 IGF-I is also known to
increase myocardial contraction,31 but excessive IGF-I may
also induce cardiac hypertrophy and impaired cardiac function,
as in individuals with acromegaly.33 Although our study did not
explore the role of IGF-I in endothelial SST PC, we may
consider elucidation of the link between NF-kB/Ikk activation
and IGF-I formation.
As SST is produced by many tissues and has various physi-
ological effects, its five SSTRs share common signaling path-
ways, such as inhibition of adenylyl cyclase, activation of
phosphotyrosine phosphatase, and modulation of MAPK
through G-protein-dependent mechanisms. Some of the
subtypes are also coupled to inward rectifying Kþ channels, to
voltage-dependentCa2þ channels, aNaþ/Hþ exchanger,AMPA/
kainate glutamate channels, phospholipaseC, and phospholipase
21T.-L. Wang, Y.-H. Yang / Journal of Acute Medicine 1 (2011) 17e22A2.24 Our previous study showed that acute effects of SST PC
involve novel signaling mechanisms, including activation of
protein kinase C, tyrosine kinases, and mitoKATP channels,
instead of systemic IGF-I activation.3 This differs from the
mechanisms mentioned above. So far, many possible physio-
logical mechanisms for SST analogs have been identifed.24,34,35
These may involve various actions of different SSTR subtypes
and the diverse distribution of these SSTRs in different tissues.
However, AP-136 or NF-kB,37 as transcription factors, may play
a central role in regulation. Todisco et al36 demonstrated that
SST inhibits AP-1 function via multiple protein phosphatases
and identified the mechanisms by which SST inhibits immediate
early gene expression. Anhod et al37 showed that SST affects
TNF-a-induced IL-6 and IL-8 secretion from pancreatic myo-
fibroblasts and that SST inhibits TNF-a-induced IL-6 secretion
in a dose-dependent manner. Although these reports were for
different tissues or cell lines, the signaling mechanism may be
similar, especially since the five SSTRs share common path-
ways. The two studies demonstrate that AP-1 and NF-kB could
be candidate factors. It is reasonable to suppose that these two
critical components could be responsible for SST-related endo-
thelial PC, especially since our results implicate NF-kB. Our
study demonstrates that TNF-a increases endothelial release of
IL-6 and IL-8 in NF-kB/Ikk-dependent pathway. SST PC
attenuated TNF-a-induced IL-6 and IL-8 release and was
involved in attenuation of TNF-a-related NF-kB activation. An
inhibitor study demonstrated that PI3K and possibly JAK-2 may
be involved in this cellular signaling. PI3K and possibly JAK-2
may be the major signaling pathways involved in modulatory
effects of SST on TNF-a-related Ikk activation.
In conclusion, SST PC modulates Ikk in a PI3K- and JAK-
2-dependent pathway, which in turn attenuates activation of
NF-kB induced by TNF-a in HUVECs.
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